LLY

1,001.79

+0.26%↑

JNJ

243.76

+0.76%↑

ABBV

226.23

+0.06%↑

NVS

161.44

+0.25%↑

AZN

196

+1.76%↑

LLY

1,001.79

+0.26%↑

JNJ

243.76

+0.76%↑

ABBV

226.23

+0.06%↑

NVS

161.44

+0.25%↑

AZN

196

+1.76%↑

LLY

1,001.79

+0.26%↑

JNJ

243.76

+0.76%↑

ABBV

226.23

+0.06%↑

NVS

161.44

+0.25%↑

AZN

196

+1.76%↑

LLY

1,001.79

+0.26%↑

JNJ

243.76

+0.76%↑

ABBV

226.23

+0.06%↑

NVS

161.44

+0.25%↑

AZN

196

+1.76%↑

LLY

1,001.79

+0.26%↑

JNJ

243.76

+0.76%↑

ABBV

226.23

+0.06%↑

NVS

161.44

+0.25%↑

AZN

196

+1.76%↑

Search

DaVita Inc

Open

BrancheGesundheitswesen

153.32 0.97

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

149.69

Max

154.11

Schlüsselkennzahlen

By Trading Economics

Einkommen

769M

1.1B

Verkäufe

200M

3.6B

KGV

Branchendurchschnitt

16.174

66.845

EPS

3.4

Gewinnspanne

29.801

Angestellte

78,000

EBITDA

81M

718M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+7.79% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

11. Mai 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

2.3B

10B

Vorheriger Eröffnungskurs

152.35

Vorheriger Schlusskurs

153.32

Nachrichtenstimmung

By Acuity

35%

65%

92 / 351 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

DaVita Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

29. Dez. 2025, 06:30 UTC

Akquisitionen, Fusionen, Übernahmen

Berkshire's Buffett Is Stepping Down. Why Little Will Change and Why That's OK. -- Barrons.com

21. März 2025, 08:19 UTC

Market Talk

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

Peer-Vergleich

Kursveränderung

DaVita Inc Prognose

Kursziel

By TipRanks

7.79% Vorteil

12-Monats-Prognose

Durchschnitt 162.5 USD  7.79%

Hoch 190 USD

Tief 144 USD

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für DaVita Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

5 ratings

1

Buy

3

Halten

1

Sell

Technischer Score

By Trading Central

142.36 / 144.275Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

92 / 351 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
help-icon Live chat